Cargando…

Patients’ preferences for bone metastases treatments in France, Germany and the United Kingdom

PURPOSE: The aim of this study was to assess patients’ preferences for efficacy, safety, and mode of administration in relation to available bone-targeted agents (BTA) for the prevention of skeletal-related events (SREs) associated with bone metastases in Europe. METHODS: Adults in France (n = 159),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hechmati, Guy, Hauber, A. Brett, Arellano, Jorge, Mohamed, Ateesha F., Qian, Yi, Gatta, Francesca, Haynes, Ian, Bahl, Amit, von Moos, Roger, Body, Jean-Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268443/ https://www.ncbi.nlm.nih.gov/pubmed/24939674 http://dx.doi.org/10.1007/s00520-014-2309-x

Ejemplares similares

Physicians’ preferences for bone metastases treatments in France, Germany and the United Kingdom
por: Qian, Yi, et al.
Publicado: (2018)

Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors
por: Qian, Yi, et al.
Publicado: (2016)

A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe
por: Body, Jean-Jacques, et al.
Publicado: (2018)

Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries
por: von Moos, Roger, et al.
Publicado: (2017)

Patient and physician preferences for first‐line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom
por: Bröckelmann, Paul J., et al.
Publicado: (2018)

Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countries
por: Body, Jean-Jacques, et al.
Publicado: (2016)

Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study
por: von Moos, Roger, et al.
Publicado: (2018)

Institutional environments and breakthroughs in science. Comparison of France, Germany, the United Kingdom, and the United States
por: Heinze, Thomas, et al.
Publicado: (2020)

International Pharmaceutical Spending Controls: France, Germany, Sweden, and the United Kingdom
por: Gross, David J., et al.
Publicado: (1994)

Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2013)

Health resource utilization associated with skeletal-related events: results from a retrospective European study
por: Body, Jean-Jacques, et al.
Publicado: (2015)

Literature review of the burden of prostate cancer in Germany, France, the United Kingdom and Canada
por: Smith-Palmer, J., et al.
Publicado: (2019)

Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion
por: Body, Jean-Jacques, et al.
Publicado: (2018)

Disability-adjusted life years lost due to diabetes in France, Italy, Germany, Spain, and the United Kingdom: a burden of illness study
por: Darbà, Josep, et al.
Publicado: (2015)

Skin toxicity and quality of life during treatment with panitumumab for RAS wild-type metastatic colorectal carcinoma: results from three randomised clinical trials
por: Koukakis, Reija, et al.
Publicado: (2016)

P936: EXPLORING HETEROGENEITY IN TREATMENT PREFERENCES OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN THE UNITED STATES, UNITED KINGDOM, FRANCE, SPAIN, ITALY AND GERMANY
por: Popat, Rakesh, et al.
Publicado: (2023)

An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries
por: Body, Jean-Jacques, et al.
Publicado: (2017)

The Economic Costs of Progressive Supranuclear Palsy and Multiple System Atrophy in France, Germany and the United Kingdom
por: McCrone, Paul, et al.
Publicado: (2011)

Emotional reactions to climate change: a comparison across France, Germany, Norway, and the United Kingdom
por: Böhm, Gisela, et al.
Publicado: (2023)

Patients’ Willingness to Accept the Risks and Benefits of New Treatments for Chronic Hepatitis C Virus Infection
por: Kauf, Teresa L., et al.
Publicado: (2012)

Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania
por: Simons, Gwenda, et al.
Publicado: (2022)

Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom
por: Botteman, M. F., et al.
Publicado: (2010)

PREFERENCES OF PATIENTS WITH MULTIPLE SCLEROSIS FOR ATTRIBUTES OF INJECTABLE MULTIPLE SCLEROSIS TREATMENTS IN THE UNITED KINGDOM AND FRANCE
por: Poulos, Christine, et al.
Publicado: (2018)

COVID-19 and Territorial Policy Dynamics in Western Europe: Comparing France, Spain, Italy, Germany, and the United Kingdom
por: Vampa, Davide
Publicado: (2021)

Potato Production in Northwestern Europe (Germany, France, the Netherlands, United Kingdom, Belgium): Characteristics, Issues, Challenges and Opportunities
por: Goffart, Jean-Pierre, et al.
Publicado: (2022)

Where Do Bone-Targeted Agents RANK in Breast Cancer Treatment?
por: von Moos, Roger, et al.
Publicado: (2013)

Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases
por: von Moos, Roger, et al.
Publicado: (2015)

Predicting EQ-5D-5L crosswalk from the PROMIS-29 profile for the United Kingdom, France, and Germany
por: Klapproth, Christoph Paul, et al.
Publicado: (2020)

The Baths of Germany, France, and Switzerland
Publicado: (1857)

The Asylums of Italy, France, and Germany
por: Arlidge, J. T.
Publicado: (1859)

The cost of Mycobacterium avium complex lung disease in Canada, France, Germany, and the United Kingdom: a nationally representative observational study
por: Goring, S. M., et al.
Publicado: (2018)

Real‐world treatment patterns and outcomes in non‐transplant newly diagnosed multiple Myeloma in France, Germany, Italy, and the United Kingdom
por: Mohty, Mohamad, et al.
Publicado: (2020)

Predicting the number of reported and unreported cases for the COVID-19 epidemics in China, South Korea, Italy, France, Germany and United Kingdom
por: Liu, Z., et al.
Publicado: (2021)

Patient Perceptions Regarding Multiple Myeloma and Its Treatment: Qualitative Evidence from Interviews with Patients in the United Kingdom, France, and Germany
por: He, Jianming, et al.
Publicado: (2021)

Public preferences for the return of research results in genetic research: A conjoint analysis
por: Bollinger, Juli, et al.
Publicado: (2014)

Hemodialysis patients’ preferences for the management of anemia
por: Hauber, Brett, et al.
Publicado: (2017)

The Asylums of Italy, Germany, and France, &c.
por: Arlidge, J. T.
Publicado: (1858)

Notes on the Asylums of Italy, France, and Germany
por: Arlidge, J. T.
Publicado: (1860)

Patients’ perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom
por: Vo, Pamela, et al.
Publicado: (2018)

A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom
por: Rigoine de Fougerolles, Thierry, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3ji14kpn1e51h66gld326vpm2l